Oral dosage form comprising a therapeutic agent and an adverse-effect agent

Details for Australian Patent Application No. 2008202531 (hide)

Owner Euro-Celtique, S.A.

Inventors Carpanzo, Anthony E.; Wright IV, Curtis

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008202531

Parent 2002326529

Filing date 6 June 2008

Wipo publication date 3 July 2008

International Classifications

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

3 July 2008 Application Open to Public Inspection

  Published as AU-A-2008202531

3 July 2008 Complete Application Filed

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202532-Method of detecting and blocking malicious activity

2008202530-Stabilizer